Ever since the Department of Justice got involved, the loose around Medtronic’s neck has been tightening. Many of these complaints were due to off-label use, though many were also referring to on-label. Th FDA has received hundreds of complaints through the years from patients and doctors alike. The irresponsible and unethical promotion led to the Department of Justice (DOJ) investigating Medtronic’s claims and settling for a larger monetary sum. This was especially apparent when the product was falsely and illegally promoted for off-label uses in certain spinal surgeries. In addition to spinal procedures, the product was later approved for tibia repairs and dental procedures by the FDA in 20, respectively. While first hailed as a game-changer in the medical community, red signs started to appear shortly after the medical device was introduced to the market. Unlike other devices with similar functions, the Infuse Bone Graft utilized a genetically-engineered (synthetic) protein called recombinant human bone morphogenetic protein (rhBMP-2) which promotes bone growth. Instead of using human bone particles to infuse broken parts of the spine, the infuse bone graft does it synthetically and supposedly with “less risk of infection”. The Infuse Bone Graft has been used in thousands of spinal fusion surgeries used to treat severe back pain.

The goal of the product was to help fuse vertebrae in a patient’s lower spine in order to treat degenerative disc disease.

It was originally approved by the Food and Drug Administration (FDA) in 2002 under the specific product name “Infuse Bone Graft/LT-CAGE Lumbar Tapered Fusion Device – P000058”. The Infuse Bone Graft is manufactured and sold by Medtronic, a medical device company in the United States. Earning wages is difficult or at times impossible, placing further pressure on an individual’s financial situation. The unfortunate combination of elongated litigation and a loss of wages is often a dangerous one and can result in devastating consequences for plaintiffs. Thankfully, Infuse Bone Graft settlement loans can level the playing field and provide injured victims with immediate monetary support. As if the long wait is not enough, injuries sustained by the Infuse Bone Graft multiply the severity of a plaintiff’s situation during such time. The duration of litigation is even more elongated when dealing with a multi-million dollar company like Medtronic. Plaintiffs who fall on hard financial times during litigation can seek help by contacting a lawsuit funding company that is willing to accept Infuse Bone Graft cases.ĭefective medical product lawsuits can drag out extensively, making plaintiffs wait years until they receive the payout award they deserve. Also known as lawsuit funding, settlement loans provide plaintiffs the ability to receive a portion of their future settlement payout now instead of later. Infuse Bone Graft settlement loans are available for plaintiffs who were injured by the product and are now pursuing a claim against Medtronic. Settlement Loans for Infuse Bone Graft Lawsuit

Infuse lawsuits